Uzsoki utcai kórház

Budapest H-1145

1 studies enrolling now · 9 studies all time

What they study most

Acute Myocardial Infarction, Bladder Cancer, Breast Cancer, Breast Neoplasms, Cartilage or Osteochondral Defects in the Knee, Chemotherapy-induced Neutropenia, Metastatic Bladder Cancer, Myelosuppression Adult, PD-L1 Positive, Triple Negative Breast Cancer, Up to Moderate Osteoarthritis, Urothelial Carcinoma

Studies at this site

• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• Agili-C™ Implant Performance Evaluation — Completed
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab — Stopped early
• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early